ArticleInternal medicine (Tokyo, Japan)2025
Quantitative Assessment of High-resolution Computer Tomography Imaging in a Super-responder to Nintedanib Therapy in a Patient with Idiopathic Pulmonary Fibrosis.
Article in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Changes in the Quantitative Computed Tomography Values in Drug-associated Interstitial Lung Disease Caused by Non-anticancer Drugs.Internal medicine (Tokyo, Japan) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nintedanib inhibits disease progression in patients with idiopathic pulmonary fibrosis (IPF) and dramatically improves the lung function in patients known to be super-responders (SRs). However, there are no reports on quantitative high-resolution computed tomography (HRCT), and the HRCT imaging characteristics of SRs remain unknown. We herein present the case of a 66-year-old man with IPF who was a SR to nintedanib treatment, which showed a marked improvement compared to other patients with IPF upon quantitative HRCT evaluation using the artificial intelligence (AI) software 3D Slicer. This study is worth reporting because a quantitative HRCT assessment using AI may be necessary to understand the SR characteristics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.